![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-6988|3|2|147-147
ISSN: 2212-697x
Source: Clinical Cancer Drugs, Vol.3, Iss.2, 2016-10, pp. : 147-147
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 3, 2002-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Acknowledgements to Reviewers:
Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Acknowledgements to Reviewers:
Letters in Drug Design & Discovery, Vol. 11, Iss. 10, 2014-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Acknowledgements to Reviewers:
Pharmaceutical Nanotechnology, Vol. 2, Iss. 4, 2014-12 ,pp. :